Kunio Shirato
Overview
Explore the profile of Kunio Shirato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
2276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koizumi J, Hara T, Sekiguchi T, Ichikawa T, Tajima H, Takenoshita N, et al.
Jpn J Radiol
. 2018 Aug;
36(11):661-668.
PMID: 30109553
Purpose: Inferior vena cava filter fracture (FF) may cause life-threatening complications, including cardiac tamponade, although the actual prevalence remains unclear. Therefore, we investigated the incidence of FF. Materials And Methods:...
2.
Sakuma M, Nakanishi N, Shirato K
Ann Vasc Dis
. 2013 Apr;
3(3):209-14.
PMID: 23555412
Objective: In Japan, there have been no reports on the time-trends of mortality rates from pulmonary heart disease without pulmonary embolism (PHD). Our aim was to examine the annual changes...
3.
Sakuma M, Nakamura M, Yamada N, Nakano T, Shirato K
Ann Vasc Dis
. 2013 Apr;
2(1):7-16.
PMID: 23555350
Background: Acute pulmonary embolism (APE) has high mortality. Some APEs with circulatory collapse or cardiopulmonary arrest have been treated by percutaneous cardiopulmonary support (PCPS) in Japan. But there have been...
4.
Itakura H, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, et al.
J Atheroscler Thromb
. 2012 Jun;
19(7):673-9.
PMID: 22653220
Aim: The Japan EPA Lipid Intervention Study (JELIS) reported a 19% reduction of the risk for coronary artery disease after long-term use of pure eicosapentaenoic acid (EPA) in Japanese patients...
5.
Long-term safety and efficacy of ambrisentan in Japanese adults with pulmonary arterial hypertension
Yoshida S, Shirato K, Shimamura R, Iwase T, Aoyagi N, Nakajima H
Curr Med Res Opin
. 2012 Apr;
28(6):1069-76.
PMID: 22506623
Objective: To investigate the safety and efficacy of long-term administration of ambrisentan in Japanese adults with pulmonary arterial hypertension (PAH). Research Design And Methods: In this open-label extension of a...
6.
Sasaki J, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, et al.
J Atheroscler Thromb
. 2011 Dec;
19(2):194-204.
PMID: 22186099
Aim: The present study examined the importance of reducing non-high-density lipoprotein cholesterol (non-HDL-C) for the primary prevention of the occurrence of coronary artery disease (CAD) in the JELIS, and the...
7.
Fukuda K, Watanabe J, Yagi T, Wakayama Y, Nakano M, Kondo M, et al.
Tohoku J Exp Med
. 2011 Aug;
225(1):35-42.
PMID: 21869589
Atrial fibrillation (AF) is the most common tachyarrhythmia. Shortening of atrial action potential duration (APD) and effective refractory period (ERP) is one of the crucial factors in the occurrence and...
8.
Yoshida S, Shirato K, Shimamura R, Nakahara N, Iwase T, Nakajima H
Curr Med Res Opin
. 2011 Aug;
27(9):1827-34.
PMID: 21812736
Objective: To investigate the efficacy, safety, and pharmacokinetics of ambrisentan in Japanese adults with pulmonary arterial hypertension (PAH). Research Design And Methods: In this open-label, uncontrolled, dose-escalation study, 25 Japanese...
9.
Miura M, Hirose M, Endoh H, Wakayama Y, Sugai Y, Nakano M, et al.
Circ J
. 2011 Apr;
75(6):1343-9.
PMID: 21467666
Background: Triggered arrhythmias arise from delayed afterdepolarizations (DADs), with Ca(2+) waves playing an important role in their formation. In ventricular hypertrophy, however, it remains unclear how Ca(2+) waves change their...
10.
Itakura H, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, et al.
J Atheroscler Thromb
. 2010 Nov;
18(2):99-107.
PMID: 21099130
Aim: The Japan EPA Lipid Intervention Study (JELIS) was the first prospective randomized clinical trial to demonstrate prevention of coronary events by pure eicosapentaenoic acid (EPA). The aim of this...